These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2647703)

  • 41. Aureobasidins, new antifungal antibiotics. Taxonomy, fermentation, isolation, and properties.
    Takesako K; Ikai K; Haruna F; Endo M; Shimanaka K; Sono E; Nakamura T; Kato I; Yamaguchi H
    J Antibiot (Tokyo); 1991 Sep; 44(9):919-24. PubMed ID: 1938613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deletions of the endocytic components VPS28 and VPS32 in Candida albicans lead to echinocandin and azole hypersensitivity.
    Cornet M; Gaillardin C; Richard ML
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3492-5. PubMed ID: 17005841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation and structural elucidation of proline-containing cyclopentapeptides from an endolichenic Xylaria sp.
    Wu W; Dai H; Bao L; Ren B; Lu J; Luo Y; Guo L; Zhang L; Liu H
    J Nat Prod; 2011 May; 74(5):1303-8. PubMed ID: 21428374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis.
    Müller FM; Kurzai O; Hacker J; Frosch M; Mühlschlegel F
    J Antimicrob Chemother; 2001 Nov; 48(5):713-5. PubMed ID: 11679561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification and Identification of Two Antifungal Cyclic Peptides Produced by Bacillus amyloliquefaciens L-H15.
    Han Y; Zhang B; Shen Q; You C; Yu Y; Li P; Shang Q
    Appl Biochem Biotechnol; 2015 Aug; 176(8):2202-12. PubMed ID: 26123083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum differentially alters the antifungal properties of echinocandin drugs.
    Paderu P; Garcia-Effron G; Balashov S; Delmas G; Park S; Perlin DS
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2253-6. PubMed ID: 17420211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Total synthesis and structure-activity relationships of new echinocandin-like antifungal cyclolipohexapeptides.
    Yao J; Liu H; Zhou T; Chen H; Miao Z; Sheng C; Zhang W
    Eur J Med Chem; 2012 Apr; 50():196-208. PubMed ID: 22348827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mohangamides A and B, new dilactone-tethered pseudo-dimeric peptides inhibiting Candida albicans isocitrate lyase.
    Bae M; Kim H; Moon K; Nam SJ; Shin J; Oh KB; Oh DC
    Org Lett; 2015 Feb; 17(3):712-5. PubMed ID: 25622093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PF1163A and B, new antifungal antibiotics produced by Penicillium sp. I. Taxonomy of producing strain, fermentation, isolation and biological activities.
    Nose H; Seki A; Yaguchi T; Hosoya A; Sasaki T; Hoshiko S; Shomura T
    J Antibiot (Tokyo); 2000 Jan; 53(1):33-7. PubMed ID: 10724005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The synthesis of water soluble prodrugs analogs of echinocandin B.
    Rodriguez MJ; Vasudevan V; Jamison JA; Borromeo PS; Turner WW
    Bioorg Med Chem Lett; 1999 Jul; 9(13):1863-8. PubMed ID: 10406656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.
    Uchida K; Nishiyama Y; Yokota N; Yamaguchi H
    J Antibiot (Tokyo); 2000 Oct; 53(10):1175-81. PubMed ID: 11132964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.
    Sehgal SN; Baker H; Vézina C
    J Antibiot (Tokyo); 1975 Oct; 28(10):727-32. PubMed ID: 1102509
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1.
    Balashov SV; Park S; Perlin DS
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2058-63. PubMed ID: 16723566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. L-671,329, a new antifungal agent. II. Structure determination.
    Wichmann CF; Liesch JM; Schwartz RE
    J Antibiot (Tokyo); 1989 Feb; 42(2):168-73. PubMed ID: 2925508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antifungal cyclic peptides from Psammosilene tunicoides.
    Tian J; Shen Y; Yang X; Liang S; Shan L; Li H; Liu R; Zhang W
    J Nat Prod; 2010 Dec; 73(12):1987-92. PubMed ID: 21070025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel echinocandin antifungals. Part 1: novel side-chain analogs of the natural product FR901379.
    Tomishima M; Ohki H; Yamada A; Maki K; Ikeda F
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1474-7. PubMed ID: 18207736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments.
    Clancy CJ; Huang H; Cheng S; Derendorf H; Nguyen MH
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2569-72. PubMed ID: 16801448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. From natural products to clinically useful antifungals.
    Barrett D
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):224-33. PubMed ID: 12084464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tensidols, new potentiators of antifungal miconazole activity, produced by Aspergillus niger FKI-2342.
    Fukuda T; Hasegawa Y; Hagimori K; Yamaguchi Y; Masuma R; Tomoda H; Omura S
    J Antibiot (Tokyo); 2006 Aug; 59(8):480-5. PubMed ID: 17080684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progressive esophagitis caused by Candida albicans with reduced susceptibility to caspofungin.
    Miller CD; Lomaestro BW; Park S; Perlin DS
    Pharmacotherapy; 2006 Jun; 26(6):877-80. PubMed ID: 16716141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.